Li S X, Huang Z S, Li S H, Zhong J L, Xie X J, Dong R M, Liu J L, Zhu J M, Zheng Z D
Department of Cardiovascular Medicine, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Department of Ultrasonography, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Oct 24;52(10):1170-1176. doi: 10.3760/cma.j.cn112148-20240827-00484.
Exploring the effect of radiofrequency ablation treatment to restore sinus rhythm on the improvement of functional mitral regurgitation (FMR) and cardiac structure in patients with atrial fibrillation combined with moderate or severe FMR, compared with drug therapy alone. This retrospective cohort study consecutively enrolled patients diagnosed with persistent atrial fibrillation and moderate or severe FMR who were admitted to the Third Affiliated Hospital of Sun Yat-sen University from January 2019 to December 2021. Forty-eight patients who were treated with radiofrequency ablation and maintained sinus rhythm were enrolled in the ablation group, and 63 patients who were treated with medication alone during the same period were in the medicine group. Patients in the ablation group and medicine group were matched in a 1∶1 ratio using a propensity score, and 41 patients were finally included in each of the 2 groups. All patients reexamined echocardiography after 3-month of treatment. The proportion of patients with FMR improvement and the differences in changes of cardiac structural and functional parameters were compared between groups. After propensity score matching, the ablation group was aged (69.3±7.1) years with 21 males (51.2%) and the medicine group was aged (71.3±9.4) years with 21 males (51.2%). The echocardiography after 3-month of treatment showed the rate of FMR improvement was significantly higher in the ablation group than in the medicine group (19 (46.3%) vs. 33 (80.5%), <0.001), and patients in the ablation group showed a significant decrease in FMR extent (Δmitral regurgitation area: (-1.30±2.64) cm vs. (-3.55±2.50) cm, <0.001), left atrial size (Δleft atrial diameter: (-0.17±3.78) mm vs. (-2.46±4.01) mm, =0.009) and E/e' (ΔE/e':-2.54±7.34 vs.-6.34±7.08, =0.021) compared with the medicine group. There was also a significant decrease in left ventricular size (Δleft ventricular end diastolic diameter: (-3.12±6.62) mm vs. (-0.73±3.62) mm, =0.046) and significant increase in left ventricular ejection fraction (Δleft ventricular ejection fraction: (2.73±9.69) % vs. (-0.93±5.41) %, =0.038) in ablation group. Performing radiofrequency ablation to restore sinus rhythm can effectively reduce the severity of mitral regurgitation and improve left atrial and left ventricular remodeling and cardiac function in patients with atrial fibrillation and FMR.
探讨射频消融治疗恢复窦性心律对房颤合并中重度功能性二尖瓣反流(FMR)患者FMR改善及心脏结构的影响,并与单纯药物治疗进行比较。这项回顾性队列研究连续纳入了2019年1月至2021年12月在中山大学附属第三医院住院的持续性房颤合并中重度FMR患者。48例接受射频消融并维持窦性心律的患者纳入消融组,同期63例单纯接受药物治疗的患者纳入药物组。采用倾向评分法将消融组和药物组患者按1∶1比例匹配,最终两组各纳入41例患者。所有患者在治疗3个月后复查超声心动图。比较两组FMR改善患者的比例以及心脏结构和功能参数变化的差异。倾向评分匹配后,消融组年龄为(69.3±7.1)岁,男性21例(51.2%),药物组年龄为(71.3±9.4)岁,男性21例(51.2%)。治疗3个月后的超声心动图显示,消融组FMR改善率显著高于药物组(19例(46.3%)对33例(80.5%),<0.001),消融组患者FMR程度(二尖瓣反流面积变化:(-1.30±2.64)cm对(-3.55±2.50)cm,<0.001)、左心房大小(左心房直径变化:(-0.17±3.78)mm对(-2.46±4.01)mm,=0.009)和E/e'(E/e'变化:-2.54±7.34对-6.34±7.08,=0.021)与药物组相比均显著降低。消融组左心室大小也显著减小(左心室舒张末期直径变化:(-3.12±6.62)mm对(-0.73±3.62)mm,=0.046),左心室射血分数显著增加(左心室射血分数变化:(2.73±9.69)%对(-0.93±5.41)%,=0.038)。进行射频消融恢复窦性心律可有效降低房颤合并FMR患者二尖瓣反流的严重程度,改善左心房和左心室重构及心脏功能。